Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia. - Wikidata - awgldk - TriplyDB

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia.

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia.

http://www.wikidata.org/entity/Q33388109

about

Immune thrombocytopenia Contemporary management of primary immune thrombocytopenia in adults Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients.Long-term management of chronic immune thrombocytopenic purpura in adults.Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters.Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia.Current treatment options for primary immune thrombocytopenia.Management of immune thrombocytopenic purpura in children: potential role of novel agents.Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients [Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].Sequence of treatments for adults with primary immune thrombocytopenia.Risk and prognosis of adult primary immune thrombocytopenia.Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis.Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia.Management of children and adolescents with primary immune thrombocytopenia: controversies and solutions.Romiplostim as early treatment of immune thrombocytopenia with severe immunodeficiency.Thrombopoietin receptor agonists in the treatment of immune thrombocytopenia: a clinician's perspective.Efficacy of rituximab in primary immune thrombocytopenia: an analysis of adult pretreated patients from everyday hematological practice.Positioning new treatments in the management of immune thrombocytopenia Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years.High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia.Eltrombopag, a thrombopoietin- receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile.Immune thrombocytopenia -- what are the new treatment options?Prednisone versus high-dose dexamethasone for untreated primary immune thrombocytopenia. A retrospective study of the Japan Hematology & Oncology Clinical Study Group.Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I study.Contemporary treatment of immune thrombocytopenia.Elevated levels of T-cell immune response cDNA 7 in patients with immune thrombocytopenia.Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration.Management of thrombocytopenia.A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study).Aberrant frequency of IL-10-producing B cells and its association with Treg/Th17 in adult primary immune thrombocytopenia patients.A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP.A Study of Human Killer Cell Immunoglobulin-Like Receptor and Multidrug Resistance Gene Polymorphisms in Children With Immune Thrombocytopenia.A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4).MicroRNA-125-5p targeted CXCL13: a potential biomarker associated with immune thrombocytopenia.The effect of single course high dose dexamethasone on CD28/CTLA-4 balance in the treatment of patients with newly diagnosed primary immune thrombocytopenia.Efficacy and safety of rituximab in Japanese patients with relapsed chronic immune thrombocytopenia refractory to conventional therapy.Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study.Rituximab salvage therapy in adults with immune thrombocytopenia: retrospective study on efficacy and safety profiles.

P2860

Q26830918-80F35F19-9772-4331-9C76-1B394FC27D40 Q26853680-21B6D34E-DA1B-44C4-BD5C-CB56FF401F7D Q33392406-30642BC6-6D0D-4339-A8E3-FB186CF5D749 Q33392610-6925CF47-7DA3-43FB-9A61-5BB022ED56BF Q33392868-A0B924D2-8517-4E41-B3C5-DA737653DEA5 Q33393434-FF5E6B77-C6F9-49B2-84E2-0B6167ACB664 Q33394149-EDC17F32-53AF-46C1-9FD0-385E547B396B Q33395863-2FC41E27-7561-4506-9F48-F37AEEE290F8 Q33397525-BE7902ED-CB1B-46B6-8F69-BA4EE7AA255A Q33400018-9ED1DE5D-FABD-4CB7-BA30-0CB7B71C7000 Q33400072-04FF0767-B0C7-4D5C-9F1F-D7AB02A9F1B4 Q33400566-871205BB-FAC5-41E2-B21D-1718CB7F9509 Q33401100-11264CAE-A021-4E4F-8C44-B20B50495EA2 Q33401321-AE8EC8E1-0F7E-4839-9ACD-A9CED3749326 Q33401898-63B7B54C-5A81-4DD6-BBAD-5AE48AF2BEDB Q33402387-E8DBD39F-6825-484E-951E-52BEE1E5E4F3 Q33402505-678C877D-6108-428B-A767-05BABE834132 Q33402591-C5362396-8982-420D-82B3-6B49988A4472 Q33404032-FA462D07-32D7-4F8F-A88E-83D365DC263A Q33404095-87CE98D4-45B2-49CC-A9FF-96015AE8F967 Q33404320-DCDCE4DC-B01F-4FF8-BA64-4A6C9A1B7428 Q33406310-D236AAAA-C2E1-49A1-ADC6-850B213CABAE Q33406838-DC00B314-70A0-43AE-9F1E-055B3939B342 Q33407802-B492A5DB-D389-4A04-A24D-E80949EFF8D8 Q33407822-0F3775BD-6322-4A59-B15E-0F8FAEEB51E0 Q33408915-F5ED1A82-000C-41A9-A6C3-4BF03A2B0FC7 Q33410653-16B8F8A0-4E10-4AD1-933B-460866CBAAAC Q33413850-74D0823B-2820-474A-8BCB-0BBB74266AE9 Q33414722-2FFB0D57-1443-4EB6-8C97-697518D79008 Q33416258-A5B14DE2-6414-4B71-BE6D-D5856F617B30 Q33416569-0D87A713-3CA8-4E47-A88C-8B780F0F8D3A Q33416700-2DD37E3B-9075-4205-8E6C-0BE999EA5F2C Q33419712-B9735F6A-D158-4F75-8A5D-F820BEC1C6B6 Q33421329-432BBAA4-5BA6-4F04-9D90-C091D121A6B5 Q33422782-5C93CD46-C323-4317-972D-37193A530F26 Q33423573-E5FE4239-D3C7-4461-BB52-5D8747875BCF Q33424754-7FD2474B-345F-4ACE-85F5-DD9C8B5C2E17 Q33426717-4144B67F-7F81-4AC7-98BF-2952DCC028BF Q33427336-B18BC812-380C-41B3-80EA-25B2E1196319 Q33431198-BF22C97B-4CC7-452F-8A90-C1C24DA8994D

P2860

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia.

http://www.wikidata.org/entity/Q33388109

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Dexamethasone plus rituximab y ...... imary immune thrombocytopenia.

@ast

Dexamethasone plus rituximab y ...... imary immune thrombocytopenia.

@en

type

label

Dexamethasone plus rituximab y ...... imary immune thrombocytopenia.

@ast

Dexamethasone plus rituximab y ...... imary immune thrombocytopenia.

@en

prefLabel

Dexamethasone plus rituximab y ...... imary immune thrombocytopenia.

@ast

Dexamethasone plus rituximab y ...... imary immune thrombocytopenia.

@en

P1433

Q33388109-F97D3D56-88EC-41CE-86B1-2C19FEEA94AC

P1476

Q33388109-C1694287-567A-494B-A27C-BC90324DC125

P2093

Q33388109-050AD4F9-D261-4AB8-BB66-F8FB588C6396

Q33388109-0A2EDEF6-CDFA-4A5F-A41E-81DE1F4A4CBE

Q33388109-12D775EB-21AD-4045-9AC5-CBB3E53E3CB7

Q33388109-1360748B-F016-4240-8B63-8256A6CCD02E

Q33388109-30C01CC6-BB21-44EF-9228-C94EFCED6AD7

Q33388109-374487CB-A175-4CDC-B159-4F2D2E0F0DA5

Q33388109-45EEE682-1D2D-45F0-917F-C645FDF28BCC

Q33388109-515D9DA6-B66D-4024-A32A-1B8D2E419D84

Q33388109-64A9570A-EA26-4C15-B240-929B3F3299AB

Q33388109-6A0FF668-7832-4845-A048-89E9FA302D86

P304

Q33388109-70DC2CFB-E87E-4EEF-BACC-120D6761B225

P31

Q33388109-BD6D9F11-2C61-4118-A494-C5AF2B5CD8CB

P356

Q33388109-D4213E91-D297-4EB8-80B0-231D1626F0FC

P407

Q33388109-E245B68B-0FF7-4D43-8033-D1FD0D864AB8

P433

Q33388109-A3D9C614-E86D-48B8-AC18-0E716C7D2A91

P478

Q33388109-B54138E0-5E43-4733-B587-F88C412CC4C4

P50

Q33388109-074F8FF7-D58C-4771-B13F-B334BC9301CC

Q33388109-0AC19305-40A7-4435-B841-2140403805D0

Q33388109-16621E12-B0FB-4F30-8880-B9A7DA93368D

Q33388109-67F8D247-931F-4C8E-B264-47B760480092

Q33388109-CD6B55AF-4D99-41F9-9BE0-A1B4329D9A9F

P577

Q33388109-BCC81C28-BC7C-4062-99D8-ED430B15BC70

P5875

Q33388109-22F0C655-2B16-4483-B976-59ED9AC713A5

P698

Q33388109-5D8C2844-EDE2-4C50-AC9C-A2A0512F0095

P921

Q33388109-3523AD85-D4BD-4A40-BC33-7C92450809ED

Q33388109-4461E4F7-180B-45DF-9D2A-7EE9EEB7E036

P356

BLOOD-2009-07-229815

P1433

P1476

Dexamethasone plus rituximab y ...... imary immune thrombocytopenia.

@en

P2093

Alessia Tieghi

http://www.w3.org/2001/XMLSchema#string

Alfonso Zaccaria

http://www.w3.org/2001/XMLSchema#string

Antonella Fornaro

http://www.w3.org/2001/XMLSchema#string

Emilio Usala

http://www.w3.org/2001/XMLSchema#string

Enrica Gamba

http://www.w3.org/2001/XMLSchema#string

Felicetto Ferrara

http://www.w3.org/2001/XMLSchema#string

Franca Soldano

http://www.w3.org/2001/XMLSchema#string

Francesco Casulli

http://www.w3.org/2001/XMLSchema#string

Francesco Zaja

http://www.w3.org/2001/XMLSchema#string

Giuseppe Visani

http://www.w3.org/2001/XMLSchema#string

P304

2755-2762

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2009-07-229815

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P50

Emanuele Angelucci

Valerio De Stefano

Michele Baccarani

P577

2010-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41405179

http://www.w3.org/2001/XMLSchema#string

P698

20130241

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia